Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

Press releases published on May 19, 2026

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
BrainHQ Awarded the Gold: Earns Trusted Digital Badge from APA Labs, a unit of American Psychological Association Services, Inc.
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
Brain Cancer Canada Invests $75,000 in Groundbreaking Glioblastoma Research at University of Alberta, Targeting How Tumours “Communicate”
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
CRB Horizons Report Reveals Food and Beverage Manufacturers Confront Aging Facilities, Labor Shortages, and Regulatory Pressure Amid Rising Safety Risks

Share this page:

Sign up for:

Iowa Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.